An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma

American Journal of Medicine

Volumn 122, Issue 11, 2009, Pages 977-991

  Krishnan, Jerry A ^a   Davis, Steven Q ^a   Naureckas, Edward T ^a   Gibson, Peter ^b   Rowe, Brian H ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute asthma; Adults; Asthma; Asthma exacerbation; Corticosteroids; Emergency department; Hospital; Review; Treatment

Indexed keywords

BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ARTIFICIAL VENTILATION; ASTHMA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; EMERGENCY WARD; ENVIRONMENTAL EXPOSURE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HUMAN; LUNG FUNCTION; MEDICAL DECISION MAKING; META ANALYSIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ASTHMA; GLUCOCORTICOIDS; HUMANS; RECURRENCE; RESPIRATORY CARE UNITS; TREATMENT OUTCOME;

EID: 71149085180     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.02.013     Document Type: Review

References (67)

1. National Heart, Blood, and Lung Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007), National Institutes of Health, Bethesda, MD Publication No. 08-4051
2. National Institutes of Health/National Heart, Lung, and Blood Institute. Data fact sheet, asthma statistics. January 1999. http://www.nhlbi.nih.gov/health/prof/lung/asthma/asthstat.pdf Accessed September 21, 2008
3. Atmar R.L., Guy E., Guntupalli K.K., et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 158 (1998) 2453-2459
4. Rosenstreich D.L., Eggleston P., Kattan M., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 336 (1997) 1356-1363
5. Friedman M.S., Powell K.E., Hutwagner L., et al. Impact of changes in transportation and commuting behaviors during the 1996 Summer Olympic Games in Atlanta on air quality and childhood asthma. JAMA 285 (2001) 897-905
6. Romieu I., Meneses F., Sienra-Monge J.J., et al. Effects of urban air pollutants on emergency visits for childhood asthma in Mexico City. Am J Epidemiol 141 (1995) 546-553
7. Galan I., Tobias A., Banegas J.R., et al. Short-term effects of air pollution on daily asthma emergency room admissions. Eur Respir J 22 (2003) 802-808
8. Lemiere C., Bai T., Balter M., et al. Adult asthma consensus guidelines update 2003. Can Respir J 11 Suppl A (2004) 9A-18A
9. Stellato C. Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol 120 (2007) 1247-1263
10. Rodrigo G., and Rodrigo C. Corticosteroids in the emergency department therapy of acute asthma. Chest 116 (1999) 285-295
11. Manser R., Reid D., and Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 1 (2001) CD001740
12. Rowe B.H., Spooner C.H., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 1 (2001) CD002178
13. Rowe B.H., Spooner C.H., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 13 (2007 July 18) CD000195
14. Edmonds M.L., Camargo Jr. C.A., Saunders L.D., et al. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database Syst Rev 3 (2000) CD002316
15. McFadden Jr. E.R., Kiser R., deGroot W.J., et al. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med 60 (1976) 52-59
16. Medical Research Council. Controlled trials of effect of cortisone acetate in status asthmaticus. Lancet 2 (1956) 803-806
17. Fanta C.H., Rossing T.H., and McFadden E.R. Glucocorticoids in acute asthma. A critical controlled trial. Am J Med 74 (1983) 845-851
18. Ratto D., Alfaro C., Sipsey J., et al. Are intravenous corticosteroids required in status asthmaticus?. JAMA 260 (1988) 527-529
19. Jones A.M., Munavvar M., Vail A., et al. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisone in acute adult asthma. Respir Med 96 (2002) 950-954
20. Hasegawa T., Ishihara K., Takakura S., et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study. Intern Med (2000) 794-797
21. Cydulka R.K., and Emerman C.L. A pilot study of steroid therapy after emergency department treatment of acute asthma: is a taper needed?. J Emerg Med 16 (1998) 15-19
22. Karan R.S., Pandhi P., Behera D., et al. A comparison of non-tapering vs tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test. Int J Clin Pharmacol Ther 40 (2002) 256-262
23. Hatton M.Q.F., Vathenen A.S., Allen M.J., et al. A comparison of abruptly stopping with tailing off oral corticosteroids in acute asthma. Respir Med 89 (1995) 101-104
24. O'Driscoll B.R., Kalra S., Wilson M., et al. Double-blind trial of steroid tapering in acute asthma. Lancet 341 (1993) 324-327
25. Lederle F.A., Pluhar R.E., Joseph A.M., and Niewoehner D.E. Tapering corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial. Arch Intern Med 147 (1987) 2201-2203
26. Lahn M., Bijur P., and Gallagher E.J. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 126 (2004) 362-368
27. Chan J.S., Cowie R.L., Lazarenko G.C., et al. Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Can Respir J 8 (2001) 147-152
28. Schuckman H., DeJulius D.P., Blanda M., et al. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. Ann Emerg Med 31 (1998) 333-338
29. Structure of a Cochrane Review. http://www.cochrane.org/review/revstruc.htm Accessed February 19, 2005
30. American Academy of Pediatrics: Policy Statement. Classifying Recommendations for Clinical Practice Guidelines. Pediatrics 114 (2004) 874-877
31. Lin R.Y., Pesola G.R., Westfal R.E., et al. Early parenteral corticosteroid administration in acute asthma. Am J Emerg Med 7 (1997) 621-625
32. Lin R.Y., Pesola G.R., Bekalchuk L., et al. Rapid improvement in peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: a randomized controlled study. Ann Emerg Med 33 (1999) 487-494
33. Littenberg B., and Gluck E. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 314 (1986) 150-152
34. Rodrigo C., and Rodrigo G. Early administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial. Respir Med 88 (1994) 755-761
35. Schneider S.M., Piper A., Britton H.L., et al. High-dose methylprednisolone as initial therapy in patients with acute bronchospasm. J Asthma 25 (1988) 189-193
36. Stein L.M., and Cole R.P. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med 112 (1990) 822-827
37. Bowler S.D., Mitchell C.A., and Armstrong J.G. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax 47 (1992) 584-587
38. Engel T., Dirksen A., Frolund L., et al. Methylprednisolone pulse therapy in acute severe asthma: a randomized, double-blind study. Allergy 45 (1990) 224-230
39. Haskell R.J., Wong B.M., and Hansen J.E. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med 143 (1983) 1324-1327
40. Marquette C.H., Stach B., Cardot E., et al. High dose and low dose systematic corticosteroids are equally efficient in acute severe asthma. Eur Respir J 8 (1995) 22-27
41. Harrison B.D., Stokes T.C., Hart G.J., et al. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet 1 (1986) 181-184
42. Guest J.F., Davie A.M., Ruiz F.J., et al. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J 14 (2005) 88-98
43. Krishnan J.A., Riekert K.A., McCoy J.V., et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 170 (2004) 1281-1285
44. Cooper W.O., and Hickson G.B. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or a hospitalization for asthma. Arch Pediatr Adolesc Med 155 (2001) 1111-1115
45. Williams L.K., Pladevall M., Xi H., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114 (2004) 1288-1293
46. Hoffman I.B., and Feil S.B. Oral versus repository corticosteroid therapy in acute asthma. Chest 93 (1988) 11-13
47. Lee C.-H., Lee C.-J., Lan R.-S., et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi 16 (1993) 25-29
48. Rowe B.H., Bota G.W., Fabris L., et al. Inhaled budesonide in addition to oral corticosteroids to prevent relapse following discharge from the emergency department: a randomized controlled trial. JAMA 281 (1999) 2119-2126
49. Brenner B.E., Chavda K.K., and Camargo C.A. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Ann Emerg Med 36 (2000) 417-426
50. Camargo Jr. C.A., and MARC Investigators. Randomized trial of medium-dose fluticasone vs placebo after an emergency department visit for acute asthma. [abstract]. J Allergy Clin Immunol 105 Pt 2 (2000) S262
51. Sin D.D., and Man S.F. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 164 (2002) 1591-1595
52. Blais L., Ernst P., Boivin J.-F., and Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital of asthma. Am J Respir Crit Care Med 158 (1998) 126-132
53. Camargo Jr. C.A., Smithline H.A., Malice M.P., et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 167 (2003) 528-533
54. Silverman R.A., Nowak R.M., Korenblat P.E., et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 126 (2004) 1480-1489
55. Rowe B.H., Wong E., Blitz S., et al. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad Emerg Med 14 (2007) 833-840
56. Green R.H., Brightling C.E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 360 (2002) 1715-1721
57. Lim K.G., and Mottram C. The use of fraction of exhaled nitric oxide in pulmonary practice. Chest 133 (2008) 1232-1242
58. Baptist A.P., Sengupta R., Pranathiageswaran S., et al. Evaluation of exhaled nitric oxide measurements in the emergency department for patients with acute asthma. Ann Allergy Asthma Immunol 100 (2008) 415-419
59. Baptist A.P., Shah B., Wang Y., et al. Exhaled nitric oxide levels during treatment in patients hospitalized with asthma. Allergy Asthma Proc 29 (2008) 171-176
60. Gibson P.G., Simpson J.L., and Saltos N. Heterogeneity of airway inflammation in persistent asthma. Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119 (2001) 1329-1336
61. Ordonez C.L., Shaughnessy T.E., Matthay M.A., et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Am J Respir Crit Care Med 161 (2000) 1185-1190
62. Norzila M.Z., Fakes K., Henry R.L., et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 161 (2000) 769-774
63. Haldar P., and Pavord I.D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 119 (2007) 1043-1052
64. Johnston S.L., Blasi F., Black P.N., et al., TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354 (2006) 1589-1600
65. Simpson J.L., Powell H., Boyle M.J., et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177 (2008) 148-155
66. De Palma A.M., Vliegen I., De Clercq E., and Neyts J. Selective inhibitors of picornavirus replication. Med Res Rev 28 (2008) 823-884
67. Castro M., Zimmerman N.A., Crocker S., et al. Asthma intervention program prevents readmission in high healthcare users. Am J Respir Crit Care Med 168 (2003) 1095-1099